• Contact us
  • Book a room
  • Intranet
  • Editor's Area
    • Homepage > Publications > hal-04854283v1
    Laboratory Publications
    Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis - Archive ouverte HAL
    Article Dans Une Revue Clinical and experimental rheumatology Année : 2024

    Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis

    Domaines

    Xavier Romand  : Connectez-vous pour contacter le contributeur

    https://hal.science/hal-04854283

    Soumis le : lundi 23 décembre 2024-13:43:36

    Dernière modification le : lundi 24 mars 2025-13:29:15

    Fichier non déposé

    Dates et versions

    hal-04854283 , version 1 (23-12-2024)

    Identifiants

    Citer

    Joey Fournier, Bastien Boussat, Benoit Dervaux, Philippe Gaudin, Xavier Romand. Cost-utility of tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis in France: a multi-state Markov model analysis. Clinical and experimental rheumatology, 2024, ⟨10.55563/clinexprheumatol/3f60yv⟩. ⟨hal-04854283⟩

    Exporter

    BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

    Collections

    51 Consultations
    0 Téléchargements

    Altmetric

    Partager

    • More